In the fourth quarter, lower sales of BIIB's multiple sclerosis drugs and Spinraza are likely to have been offset by revenues from new drugs.
came under fire for delaying its decision on whether the breakthrough drug beta interferon should be available to all MS sufferers on the NHS. Catherine, who had to fight for her right to have the ...
Physicians are the only professionalso who can tell a stranger, “Go in that room, put on a gown, and take off all your clothes,” and the patient will unquestioningly comply. However, many ...
Trump also rescinded an executive order that prompted the Center for Medicare and Medicaid Innovation to create three drug pricing experiments that haven’t gotten fully off the ground yet.
C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...
The warning follows 82 global anaphylaxis cases, emphasizing the importance of vigilance in monitoring MS medication side effects. FDA adds boxed warning to a multiple sclerosis drug, citing rare ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA ...
The US Food and Drug Administration (FDA) has added a boxed warning to the label of multiple sclerosis drug glatiramer acetate about the risk of anaphylaxis. From December 1996 through May 2024 ...
The FDA has released a Drug Safety Communication and added a boxed warning ... Both are used to treat patients with multiple sclerosis, and they work by lessening the immune system’s abnormal attack ...
Common medications might hold the key to preventing dementia, according to a vast study. Repurposing drugs like antibiotics could offer a swift and economical approach to managing dementia, suggesting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback